Please login to the form below

Not currently logged in
Email:
Password:

Canada invests in genomics

Canadian state ploughs millions into genomics research fund in an attempt to attract and retain leading scientists

The Canadian state of Ontario is launching a new fund to attract and retain world-leading genomics researchers in the province.

The $100m Global Leadership Round in Genomics and Life Science will support globally significant, collaborative research projects that are headquartered in Ontario, creating high-skilled jobs in research and technology. The move brings the province's investments in science since 2003 to $1.4bn.

Focused on genomics and gene-related research, the new fund will aim to accelerate new knowledge that could lead to cures, better treatment and prevention for diseases such as cancer, diabetes and heart disease. The fund will also support innovation in agriculture, environmental protection and clean technologies.

"At a time when economic challenges are tempting some governments to scale back on their innovation spending, Ontario is more committed than ever to its vision of global leadership through collaboration. The Ontario government is committed to growing an innovation economy that supports the groundbreaking work of our leading scientists and their teams. New discoveries and breakthroughs will continue to be made – and we want those people, those ideas, and those jobs right here in Ontario," said Minister of Research and Innovation, John Wilkinson.

Investing in research and innovation has been a cornerstone of Ontario's economic planning since 2003 and Ontario's Innovation Agenda. The agenda is a $3.2bn initiative to make the province one of the best places in the world to for leading research.

11th May 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics